Related Experiment Video
Updated: May 1, 2026

Human Dupuytren's Ex Vivo Culture for the Study of Myofibroblasts and Extracellular Matrix Interactions
Published on: April 18, 2015
Contemporary management of dupuytren contracture
Marco Rizzo1, Peter J Stern, Prosper Benhaim
1Associate Professor, Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.
Abstract:
Dupuytren contracture is a condition that affects the palmar fascia. It most commonly affects men of northern European ancestry and initially presents at middle age. The diseased fascia may form cords that extend into the digits, resulting in limited motion and function. Treatment is aimed at either releasing or removing the diseased cord so that the finger can extend fully. Common interventions include surgery, needle aponeurotomy, and collagenase injection. Surgery remains the gold standard in treatment and most commonly includes a limited fasciectomy. Although often successful, surgery carries inherent risks and may involve a lengthy recovery with extensive therapy. Needle aponeurotomy and collagenase injections are office-based alternatives that aim to weaken the cord and release the contracture. Needle aponeurotomy involves repeated needling along the cord in intervals and collagenase injections to dissolve a portion of the cord. Despite being less invasive, problems such as nerve and/or tendon injury, skin tears, and autoimmune reactions have been reported. Regardless of treatment, recurrence remains a concern.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Pericarditis III: Medical Management
Peripheral Artery Disease IV: Nursing Management

